Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CDKN2A overexpression
i
Other names:
CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1029
Related biomarkers:
Expression
Mutation
CNA
Others
‹
CDKN2A negative (5)
CDKN2A expression (0)
CDKN2A negative (5)
CDKN2A expression (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CDKN2A overexpression
Soft Tissue Sarcoma
CDKN2A overexpression
Soft Tissue Sarcoma
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
olaparib
Sensitive: C3 – Early Trials
olaparib
Sensitive
:
C3
CDKN2A overexpression
Ovarian Cancer
CDKN2A overexpression
Ovarian Cancer
palbociclib
Sensitive: D – Preclinical
palbociclib
Sensitive
:
D
palbociclib
Sensitive: D – Preclinical
palbociclib
Sensitive
:
D
CDKN2A overexpression
Mantle Cell Lymphoma
CDKN2A overexpression
Mantle Cell Lymphoma
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
venetoclax
Sensitive: D – Preclinical
venetoclax
Sensitive
:
D
CDKN2A overexpression
Estrogen Receptor Positive Breast Cancer
CDKN2A overexpression
Estrogen Receptor Positive Breast Cancer
CDK4 inhibitor + CDK6 inhibitor
Resistant: D – Preclinical
CDK4 inhibitor + CDK6 inhibitor
Resistant
:
D
CDK4 inhibitor + CDK6 inhibitor
Resistant: D – Preclinical
CDK4 inhibitor + CDK6 inhibitor
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.